Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective study
BackgroundThe objective of this study is to investigate the predictive role of O6-methylguanine-DNA methyltransferase (MGMT) and isocitrate dehydrogenase (IDH) status on the efficacy of bevacizumab (BEV) in high-grade glioma (HGG), while excluding the interference of chemotherapy agents.MethodsA ret...
Saved in:
| Main Authors: | Bai Xuexue, Yan Chengrui, Wenbin Ma, Feng Ming, Wu Chao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1634892/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
IDH mutation and MGMT methylation status in glioblastoma and other gliomas patients: a Russian retrospective cohort study
by: Moez Eid, et al.
Published: (2025-05-01) -
The relationship between IDH, P53 mutations, MGMT methylation with characteristics in high grade glioma patients
by: Duc Anh Tran, et al.
Published: (2022-07-01) -
Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas
by: D. V. Tabakov, et al.
Published: (2017-04-01) -
Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas
by: Xinli Zhang, et al.
Published: (2024-12-01) -
Vorasidenib- A Paradigm Shift in IDH1- or IDH2-Mutant Low-Grade Glioma Treatment
by: Hurais Malik, et al.
Published: (2024-09-01)